Breaking News
Get Actionable Insights with InvestingPro+: Start 7 Day FREE Trial Register here
Investing Pro 0
Ad-Free Version. Upgrade your Investing.com experience. Save up to 40% More details

Pfizer to complete supply of COVID-19 vaccines to EU by September

Stock MarketsDec 28, 2020 16:15
Saved. See Saved Items.
This article has already been saved in your Saved Items
 
© Reuters. FILE PHOTO: COVID-19 vaccine in Bad Windsheim

By Francesco Guarascio

BRUSSELS (Reuters) - The distribution of an initial 200 million doses of the COVID-19 vaccine developed by Pfizer (NYSE:PFE) and BioNTech across the European Union will be completed by September, a spokesman for the EU Commission said on Monday.

The protracted timetable, which was previously unknown, confirms that the bloc, with a population of 450 million, will need vaccines from other suppliers to speed up inoculations against the coronavirus.

Most EU countries began inoculating healthcare workers and vulnerable people on Sunday with the Pfizer vaccine, which is the only one so far authorised in the 27-nation bloc, and requires a two-dose regimen.

"Distribution of the full 200 million doses is scheduled to be completed by September 2021," the spokesman told Reuters in an emailed statement.

A spokesman for Pfizer declined to comment on specific schedules or whether the timeline indicated by the Commission represented a delay in planned supplies, adding: "Our timelines are aspirational and can shift based on capacity and manufacturing timelines. These considerations will in turn refine supply projections and delivery schedules".

Talks are underway on delivery of a further 100 million doses which are optional under the contract sealed with the two companies, the EU spokesman said, confirming an earlier report from Reuters.

The timetable for the additional doses is unclear.

Pfizer's spokesman said the option for another 100 million doses had not been concluded.

The EU spokesman said most supply contracts agreed by the EU with COVID-19 vaccine makers foresee the majority of deliveries completed by the end of next year.

The EU has signed advance purchase agreements with Pfizer-BioNTech, AstraZeneca, Johnson & Johnson (NYSE:JNJ), Moderna (NASDAQ:MRNA), Sanofi (PA:SASY) and CureVac for a total of nearly 2 billion doses.

The bloc's drug regulator is to decide on the possible approval of the Moderna vaccine on Jan. 6, and has said that it could receive applications for approval from AstraZeneca and Johnson & Johnson in the first quarter of next year.

The EU Commission spokesman added that under some of the agreed contracts, first deliveries could start by March.

Pfizer to complete supply of COVID-19 vaccines to EU by September
 

Related Articles

Add a Comment

Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

Write your thoughts here
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn`t bear any responsibility for any trading losses you might incur as a result of using this data.

Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.
Continue with Google
or
Sign up with Email